Insider Cluster (3 insiders) ·Filed Apr 23, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight • Neutral

This cluster is too small to warrant a trading signal. Monitor the next earnings release for any fundamental catalyst; insider activity at these levels is noise for a $2B biotech.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
PHVS ▲ +22.94% at T+60d
NEUTRAL call ✓ call won +22.94% · α vs SPY +17.92% · entry $27.29 → $33.55
Entry anchored
Apr 22, 03:59 PM ET
via exchange tick
T+1d
+4.91%
call +4.91% · α +4.13%
$28.63
settled 5mo ago
T+5d
+13.63%
call +13.63% · α +12.15%
$31.01
settled 5mo ago
T+20d
+7.92%
call +7.92% · α +3.28%
$29.45
settled 5mo ago
T+60d
+22.94%
call +22.94% · α +17.92%
$33.55
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Three Pharvaris insiders sold a total of $118K in stock over a one-week window, with the Chief Medical Officer accounting for the bulk ($112K) via option exercises and same-day sales. The dollar amount is trivial relative to the $2.0B market cap (0.006%), making this a routine cluster with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$118.0K
Insiders
3

Key Facts

  • Three insiders sold shares totaling $118K from April 22-29, 2026
  • Chief Medical Officer Lu Peng sold $112K via option exercise and same-day open-market sale
  • Total cluster value is 0.006% of Pharvaris' $2.0B market cap
  • Chief Early Development Officer and a Director each sold $3K — de minimis amounts
  • All sales were pre-planned or routine; no insider buying in the cluster

Financial Impact

Insider sales of $118K represent 0.006% of market cap — immaterial

insider holdings

Risk Factors

  • No material risk identified from this cluster alone
  • If a larger insider sale cluster emerges (>$1M or >0.1% of market cap), it would warrant attention

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
84% bullish (19 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PHVS-1777677017703
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.07 (+18.38%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.07 (−18.38%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.07 (−20.06%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.07 (−18.29%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.07 (−17.90%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.07 (−14.80%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.07 (−9.83%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.07 (−6.49%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.07 (−8.25%)
Showing 10 of 37

US Market Status

Market Open — Closes in 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 1, 2026